Literature DB >> 90472

[The effects of gammaglobulins in resistant epilepsies. A preliminary study (author's transl)].

F Laffont, S Esnault, A Gilbert, M A Peytour, H P Cathala, J P Eygonnet.   

Abstract

The effect of injections of gammaglobulins 16 Mérieux (1 ml/kg) was studied in 9 patients aged from 1 to 35 years suffering from epilepsy resistant to conventional anticonvulsant treatment. Different types of epilepsy were studied to try to discover a possible indication as a function of the type of epilepsy. Results were assessed according to the patients' behaviour, the frequency and severity of clinical fits, the results of psychological tests, and EEG tracing recorded over long periods of time. Recordings were repeated every 2 to 3 weeks. Favourable results were observed in 7 cases with: --an increased rate of sleeping and waking EEG tracings, --a reduction in the percentage of paroxysms whatever the wakefulness stage, --alterations in the percentages of some sleep stages. The possible mechanisms of action of IgG are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90472

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  4 in total

Review 1.  High dose intravenous gamma-globulin in intractable epilepsy of childhood.

Authors:  A Etzioni; M Jaffe; S Pollack; N Zelnik; A Benderly; Y Tal
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 2.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

3.  Use of intravenous immunoglobulins in drug-resistant epilepsy.

Authors:  A Fois; M Vascotto
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 4.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.